Spanish guidelines for the management of autosomal dominant polycystic kidney disease

ABACUS/Manakin Repository

Show simple item record

dc.contributor.author Ars, E.
dc.contributor.author Bernis, C.
dc.contributor.author Fraga, G.
dc.contributor.author Martínez, V.
dc.contributor.author Martins Muñoz, Judith Fátima
dc.contributor.author Ortiz, A.
dc.contributor.author Torra, R.
dc.contributor.author Pérez, M. V.
dc.contributor.author Antón Pérez, G.
dc.contributor.author Furlano, M.
dc.contributor.author Ayasreh, N.
dc.date.accessioned 2015-07-14T18:36:47Z
dc.date.available 2015-07-14T18:36:47Z
dc.date.issued 2014
dc.identifier.citation Ars, E., Bernis, C., Fraga, G., Martínez, V., Martins, J., Ortiz, A., Pérez, M.V., Antón Pérez G., Furlano, M., Ayasreh, N. . (2014). Spanish guidelines for the management of autosomal dominant polycystic kidney disease. Nephrology Dialysis Transplantation, 29(suppl 4), iv95-iv105. spa
dc.identifier.issn 09310509
dc.identifier.issn 14602385
dc.identifier.uri http://hdl.handle.net/11268/4195
dc.description.abstract Autosomal dominant polycystic kidney disease (ADPKD) is the most frequent cause of genetic renal disease and accounts for 6-10% of patients on renal replacement therapy (RRT). Very few prospective, randomized trials or clinical studies address the diagnosis and management of this relatively frequent disorder. No clinical guidelines are available to date. This is a consensus statement presenting the recommendations of the Spanish Working Group on Inherited Kidney Diseases, which were agreed to following a literature search and discussions. Levels of evidence found were C and D according to the Centre for Evidence-Based Medicine (University of Oxford). The recommendations relate to, among other topics, the use of imaging and genetic diagnosis, management of hypertension, pain, cyst infections and bleeding, extra-renal involvement including polycystic liver disease and cranial aneurysms, management of chronic kidney disease (CKD) and RRT and management of children with ADPKD. Recommendations on specific ADPKD therapies are not provided since no drug has regulatory approval for this indication. spa
dc.language.iso eng spa
dc.subject.other Enfermedad renal spa
dc.title Spanish guidelines for the management of autosomal dominant polycystic kidney disease spa
dc.type article spa
dc.description.impact 3.577 JCR (2014) Q1, 11/76 Urology & nephrology; Q2, 7/25 Trasplantation spa
dc.identifier.doi 10.1093/ndt/gfu186
dc.rights.accessRights closedAccess spa
dc.subject.uem Cardiología spa
dc.subject.unesco Enfermedad cardiovascular spa
dc.description.filiation UEM spa
dc.peerreviewed Si spa

Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record